Age at Diagnosis of Neurofibromatosis 1: An Audit of Practice
Author(s) -
S. Abecassis,
Sylvie BastujiGarin,
Kiarash Khosrotehrani,
J Zeller,
J. Revuz,
P. Wolkenstein
Publication year - 2008
Publication title -
dermatology
Language(s) - English
Resource type - Journals
eISSN - 1421-9832
pISSN - 1018-8665
DOI - 10.1159/000116622
Subject(s) - neurofibromatosis , plexiform neurofibroma , medicine , pediatrics , neurofibroma , dysplasia , age of onset , dermatology , disease , pathology
Neurofibromatosis 1 (NF1) is a common genetic disease with an incidence of about 1 in 2,500, an autosomal dominant mode of inheritance and a high rate of new mutations. Two striking aspects of NF1 are its progression with age and its extreme variability. Its diagnosis is based on 7 criteria of which 2 are required for diagnosis: significant cafe-au-lait macules (CLM), neurofibromas of any type or 1 plexiform neurofibroma, freckling in the axillary or inguinal regions, optic glioma, Lisch nodules, a distinctive osseous lesion such as sphenoid dysplasia or thinning of the long bone cortex with or without pseudarthrosis, a first-degree relative with NF1. Although specificity and sensitivity of these criteria are high during adulthood, their sensitivity is low during early childhood: 97% of NF1 patients meet them by the age of 8 years, but only 70% by the age of 1 year. In France, the diagnosis is often made in young adults, and the detection of the early complications needs precocious diagnosis . We conducted a retrospective audit of practice to identify features associated with early diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom